A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation

Circulation

Volumn 93, Issue 2, 1996, Pages 215-222

  Hall, Patrick ^a   Nakamura, Shigeru ^b   Maiello, Luigi ^a   Itoh, Akira ^a   Blengino, Simonetta ^a   Martini, Giovanni ^a   Ferraro, Massimo ^a   Colombo, Antonio ^a,c  

^a EMO GVM CENTRO CUORE COLUMBUS   (Italy)

^b TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

^c Centro Coure Columbus   (Italy)

Author keywords

stents; ultrasonics

Indexed keywords

ACETYLSALICYLIC ACID; TICLOPIDINE;

ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART INFARCTION; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; STENT; THROMBOSIS; ULTRASOUND;

EID: 0030070652     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.2.215     Document Type: Article

References (40)

1. Roubin GS, Cannon AD, Agrawal SK, Macander PJ, Dean LS, Baxley WA, Breland J. Intracoronary stenting for acute or threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation. 1992;85:916-927.
2. George BS Voorhees WD, Roubin GS, Fearnot NE, Pinkerton CA, Raizner AE, King SB, Holmes DR, Topol ER, Kereiakes DJ, Hartzler GO. Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: clinical and angiographic outcomes. J Am Coll Cardiol. 1993;22:135-143.
3. Fischman DL, Leon MB, Baim D, Schatz RA, Penn I, Detre K, Savage MP, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein P, Fish D, Colombo A, Brinker J, Moses J, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldberg S. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331: 496-501.
4. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy J-J, van den Huevel P, Delcan J, Morel MA, for the BENESTENT Study Group. A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331:489-495.
5. Herrman NC, Buchbinder M, Clemen MW, Fischman D, Goldberg S, Leon M, Schatz RA, Tierstein P, Walker CM, Hirshfield JW. Emergent use of balloon expandable coronary artery stenting for failed percutaneous transluminal coronary angioplasty. Circulation. 1992;86:812-819.
6. Nath FC, Muller DWM, Ellis SG, Rosenschein U, Chapekis A, Quain L, Zimmerman C, Topol EJ. Thrombosis of a flexible coil coronary stent: frequency, predictors, and clinical outcomes. J Am Coll Cardiol. 1993;21:622-627.
7. Kimura T, Nosaka H, Yokoi H, Iwabuchi M, Nobuyoshi M. Serial angiographic follow-up after Palmaz-Schatz stent implantation: comparison with conventional balloon angioplasty. J Am Coll Cardiol. 1993;21:1557-1563.
8. Carrozza JP, Kuntz RE, Levine MJ, Pomerantz RM, Fishman RF, Mansour M, Gibson CM, Senerchia CC, Diver DJ, Safian RD, Baim DS. Angiographic and clinical outcome of intracoronary stenting: immediate and long-term results from a large single center experience. J Am Coll Cardiol. 1992;20:328-337.
9. Nakamura S, Colombo A, Gaglione S, Almagor Y, Goldberg SL, Maiello L, Finci L, Tobis JM. Intracoronary ultrasound observations during stent implantation. Circulation. 1994;89:2026-2034.
10. Goldberg SL, Colombo A, Nakamura S, Almagor M, Maiello L, Tobis JM. The benefit of intracoronary ultrasound in the deployment of Palmaz-Schatz stents. J Am Coll Cardiol. 1994;24: 996-1003.
11. Hall P, Colombo A, Almagor Y, Maiello L, Nakamura S, Martini G, Tobis JM. Preliminary experience with intravascular ultrasound guided Palmaz-Schatz stenting: the acute and short term results on a consecutive series of patients. J Intervent Cardiol. 1994;7:141-159.
12. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G, Gaglione A, Goldberg SL, Tobis JM. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 1995;91:1676-1688.
13. Russo RJ, Schatz RA, Sklar MA, Johnson AD, Tobis JM, Teirstein PS. Ultrasound guided coronary stent placement without prolonged systemic anticoagulation. J Am Coll Cardiol. 1995;25:50A. Abstract.
14. Blasini R, Mudra H, Schulen H, Regar E, Klauss V, Zitzman E, Paloncy R, Neller P, Neumann FJ, Richardt G, Schmitt C, Schomig A. Intravascular ultrasound guided optimized emergency coronary Palmaz-Schatz stent placement without post procedural systemic anticoagulation. J Am Coll Cardiol. 1995;25:197A. Abstract.
15. Morice MC, Bourdonnec C, Biron Y, Fajadet J, Glatt B, Royer T, Descaves C, Gaspard P, Lienhard Y, Marco J. Coronary stenting without Coumadin: phase III. J Am Coll Cardiol. 1994;23:335A. Abstract.
16. Barragan PT, Silvestri MA, Sainsous JB, Bouvier JL, Comet BL, Simeoni JB. Coronary stenting without anticoagulation. J Am Coll Cardiol. 1994;23:336A.
17. Elias J, Monassier JP, Puel J, Grollier G, Khalife K, Hanssen M, Labbe T, Boulenc JM, Lavai G. Medronic Wiktor stent implantation without Coumadin: hospital outcome. Circulation. 1994; 90(suppl I):I-124. Abstract.
18. Aubry P, Royer T, Spaulding C, Lancelin B, Faivre R, Henry M, Livarek B, Rioux P, Valette B, Masquet C, Morice MC, Zemour G. A lower rate of complications after Gianturco-Roubin coronary stenting using a new antiplatelet and anticoagulant protocol. Circulation. 1994;90(suppl I):I-124. Abstract.
19. Carvalho H, Fajadet J, Jordan C, Cassagneau B, Robert G, Marco J. Reduction of subacute stent thrombosis rate after coronary stenting using a new anticoagulant protocol. Circulation. 1994; 90(suppl I):I-125. Abstract.
20. Jordan C, Carvalho H, Fajadet J, Cassagneau B, Robert G, Marco J. Reduction of subacute stent thrombosis rate after coronary stenting using a new anticoagulant protocol. Circulation. 1994; 90(suppl I):I-125.
21. Barragan P, Silvestri M, Sainsous J, Simeoni JB, Bayet G, Bouvier JL, Comet B. Prevention of subacute occlusion after coronary stenting with ticlopidine regimen without intravascular ultrasound guided stenting. J Am Coll Cardiol. 1995;25:182A. Abstract.
22. Morice MC, Breton C, Bunouf P, Cattan S, Eltchaninoff H, Henry M, Joly P, Livarek B, Pillere R, Rioux P, Spaulding C, Zemour G. Coronary stenting without anticoagulant, without intravascular ultrasound results of the French registry. Circulation. 1995;92:I-796. Abstract.
23. Colombo A, Hall P, Thomas J, Almagor Y, Find L. Initial experience with the disarticulated (one-half) Palmaz-Schatz stent: a technical report. Cathet Cardiovasc Diagn. 1992;25:304-308.
24. Nakamura S, Hall P, Blengino S, Maiello L, Itoh A, Finci L, Colombo A. Reproducibility of intravascular ultrasound measurements. Eur Heart J. 1995;16:201. Abstract.
25. Scoblianko DP, Brown G, Mitten S. A new digital electronic caliper for measurement of coronary arterial stenosis: a comparison with visual and computer assisted measurements. Am J Cardiol. 1984;53: 689-693.
26. Theron HT, Lambert CR, Pepine CJ. Video densitometry versus digital calipers for quantitative coronary angiography. Am J Cardiol. 1990;66:1886-1890.
27. Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB 3rd, Loop FD, Peterson KL, Reeves TJ, Williams DO, Winters WL Jr. Guidelines for percutaneous transluminal coronary angioplasty: a report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures. Circulation. 1988;78:486-502.
28. The TIMI Study Group. The thrombolysis in acute myocardial infarction trial. N Engl J Med. 1985;312:932-936.
29. Hass WK, Easton JD, Adams HP Jr, Pryse-Phillips W, Molony BA, Anderson S, Kamm B, for the Ticlopidine Aspirin Stroke Study Group. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high risk patients. N Engl J Med. 1989;321:501-507.
30. Piscotta V. Drug induced agranulocytosis. Drugs. 1978;15:132-143.
31. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathophysiology of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326:242-250, 310-318.
32. Lefkovits J, Plow EF, Topol EJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med. 1995;332: 1553-1559.
33. Couglin SR, Vu THH, Hung DR, Wheaton VI. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. J Clin Invest. 1992;89:351-355.
34. Coller BS. Platelets in cardiovascular thrombosis and thrombolysis. In: Fozard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The Heart and Cardiovascular System: Scientific Foundations. 2nd ed. New York, NY: Raven Press; 1991;1:219-273.
35. Berridge MJ. Inositol triphosphate and diacylglycerol: two interacting second messengers. Annu Rev Biochem. 1987;56:159-193.
36. Coller BS, Peerschke EI, Scudder LE, Sullivan CA. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thromasthenic-like state in normal platelets and binds to gycoprotein IIb and or IIIa. J Clin Invest. 1983;72:325-338.
37. Bernat A, Vallee E, Maffrand JP, Gordan JL. The role of platelets and ADP in experimental thrombosis induced by venous stasis in the rat. Thromb Res. 1988;52:65-70.
38. Maffrand JP, Defreyn G, Bernat A, Delebassee D, Tissinier AM. Reviewed pharmacology of ticlopidine. Angiologie Suppl. 1988;77: 6-13.
39. Hardisty RM, Fowling MJ, Nokes TJC. The action of ticlopidine on human platelets: studies on aggregation, secretion, calcium mobilization, and membrane glycoproteins. Thromb Haemost. 1990;64: 105-115.
40. Serruys PW, Emanuelsson H, Macaya C, Rutsch W, Heydrickx G, Suryapranata H, Legrand V, Guy J-J, Materne P, Bonnier H. BNESTENT-II Pilot Study: in-hospital results of phase 1, 2, 3, 4. Eur Heart J. 1995;290:16.